Skip to main content
Equibles

Magda Michna

Staar Surgical Co (STAA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Magda Michna

Staar Surgical Co reported in an 8-K filed March 18, 2025 that Magda Michna was appointed Chief Development Officer, effective March 17, 2025. The proxy statement of Staar Surgical Co reports total compensation of $2,695,752 for Magda Michna in fiscal 2025, including a base salary of $516,819. Disclosed compensation is on record for 2 fiscal years.

“the Board appointed Magda Michna, PhD, the Company's Chief Clinical, Regulatory and Medical Affairs Officer, to the newly created role of Chief Development Officer, reporting to Mr. Foust.”
Staar Surgical Co Form 8-K, filed March 18, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Staar Surgical Co

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Staar Surgical Co (STAA) $516,819 $2,695,752
2024 Staar Surgical Co (STAA) $492,904 $2,313,683

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.